fda glp-1 warning letters october 2025 Are weight loss compounds safe? Not from this San Francisco telehealth startup and its former supplier, whistleblowers say. @nbcbayarea #weinvestigate #glp1community #glp1 #weightlossjourney Letter to FDA's Office of

GLP1 response to oral glucose is reduced in prediabetes, screendetected type 2 diabetes, and obesity and influenced by sex: The ADDITIONPRO study

Ueda P, Wintzell V, Melbye M, Eliasson B, Soderling J, Gudbjornsdottir S, et al

Tirzepatide also activates a related GIP receptor, giving it a dual effect that often leads to greater weight reduction

However, BMI isnt the only thing we consider

1,2 More importantly, they reduce life expectancy by 814 years on average, 2,3 often due to cardiometabolic comorbidities

Zepbound and Mounjaro contain the same active ingredient (tirzepatide), are both given as weekly injections, and both are made by Eli Lilly and Company